HeartStart MRx Monitor/Defibrillator Model # M3535A - Product Usage: The HeartStart MRx is a lightweight, portable external defibrillator, offering two modes of operation for defibrillation: manual mode and semi-automatic mode (AED). In manual mode, the HeartStart MRx is a full featured manual defibrillator, designed for use by clinicians trained in Advanced Cardiac Life Support (ACLS). Manual operation allows users to select energy levels for external and internal defibrillation. Users may also perform synchronized cardioversion. Non-invasive external pacing is a device option. In AED mode, the HeartStart MRx allows the provider who is trained in Basic Life Support (BLS) to provide defibrillation therapy. The device analyzes a patient s rhythm and advises the user to deliver a shock. Voice prompts guide the user through the defibrillation process by providing instructions and patient information. The voice prompts are reinforced by messages that appear on the display. In both modes of operation, the HeartStart MRx utilizes impedance compensating biphasic truncated exponential therapy waveform. The HeartStart MRx can also be used for ECG monitoring of a patient using 3, 5 or 12 lead cables.
Published September 18, 2019 · Recall initiated: July 16, 2019
Summary
FDA records medical device Class II recall Z-2488-2019, published September 18, 2019 and initiated July 16, 2019. Recalling firm: Philips North America, LLC; Status: Terminated; Reported quantity: 2 units; Lot: Lot/ Serial # US00539461, US00539462. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Non-conforming devices are identified, which may not have been included in prior field actions and may not have had a number of corrections applicable to these devices.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Philips North America, LLC
- Distributor
- US Nationwide distribution in the state of MA.
- Lot
- Lot/ Serial # US00539461, US00539462
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAThe IFU for the Autoclavable Temperature Probes: Part # 453564635891, providing in the packaging for theApril 20, 2022
- FDAPhilips Sterilizable Defibrillator Paddles, Switched Internal Paddles, Model Numbers M4741A, M4742A, M4743A,November 4, 2020
- FDAPhilips SureSigns VM1SpO2, C02, Rec, model no. 863266 - Product Usage: The SureSigns VM1 is a patient monitorJune 17, 2020
- FDAPhilips HeartStart XL Defibrillator/Monitor (Model number M4735A) - Product Usage: is for use in the hospitalMay 27, 2020
- FDAROTEM ex-tem Rest of the world part No: 503-05 (ROW)September 18, 2019
- FDAMedtronic Micra MC1VR01, REF MC1VR01 (OUS only). Cardiac pacemaker.September 18, 2019
Questions about this recall
Was HeartStart MRx Monitor/Defibrillator Model # M3535A - Product Usage: The HeartStart MRx is a lightweight, portable external defibrillator, offering two modes of operation for defibrillation: manual mode and semi-automatic mode (AED). In manual mode, the HeartStart MRx is a full featured manual defibrillator, designed for use by clinicians trained in Advanced Cardiac Life Support (ACLS). Manual operation allows users to select energy levels for external and internal defibrillation. Users may also perform synchronized cardioversion. Non-invasive external pacing is a device option. In AED mode, the HeartStart MRx allows the provider who is trained in Basic Life Support (BLS) to provide defibrillation therapy. The device analyzes a patient s rhythm and advises the user to deliver a shock. Voice prompts guide the user through the defibrillation process by providing instructions and patient information. The voice prompts are reinforced by messages that appear on the display. In both modes of operation, the HeartStart MRx utilizes impedance compensating biphasic truncated exponential therapy waveform. The HeartStart MRx can also be used for ECG monitoring of a patient using 3, 5 or 12 lead cables. recalled?
Yes. FDA published recall Z-2488-2019 on September 18, 2019. Reported hazard: Non-conforming devices are identified, which may not have been included in prior field actions and may not have had a number of corrections applicable to these devices.
What should I do if I have this product?
Voluntary: Firm initiated · Letter